Research graph
References from Implementing a Risk-Stratified National Breast Screening Programme in the United Kingdom: A Model-Based Cost-effectiveness Analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Breast Screening (Mammogram)
2021 · External reference
A breast cancer prediction model incorporating familial and personal risk factors
10.1002/sim.1668 · 2004 · External reference
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort
10.1186/s13058-015-0653-5 · 2015 · External reference
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer
2013 · External reference
Criteria for a population screening programme. GOV.UK
2022 · External reference
Estimating the cost of 3 risk prediction strategies for potential use in the United Kingdom National Breast Screening Program
10.1177/23814683231171363 · 2023 · External reference
Evaluation of a stratified national breast screening program in the United Kingdom: an early model-based cost-effectiveness analysis
10.1016/j.jval.2017.04.012 · 2017 · External reference
Unresolved reference
2025 · External reference
The cost-effectiveness of risk-stratified breast cancer screening in the UK
10.1038/s41416-023-02461-1 · 2023 · External reference
Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model
10.1001/jamaoncol.2018.1901 · External reference
Cost-effectiveness of AI for risk-stratified breast cancer screening
10.1001/jamanetworkopen.2024.31715 · 2024 · External reference
Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density
10.1001/jamaoncol.2018.0174 · External reference
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
10.1136/bmj-2021-067975 · 2022 · External reference
What are the benefits and harms of risk stratified screening as part of the NHS Breast Screening Programme? study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420)
10.1186/s12885-020-07054-2 · 2020 · External reference
10.22024/unikent/01.02.84818
10.22024/unikent/01.02.84818 · 2021 · External reference
Unresolved reference
2023 · External reference
Breast cancer tumor growth estimated through mammography screening data
10.1186/bcr2092 · 2008 · External reference
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and Family History Clinic: a dual cohort study
2015 · External reference
TNM staging for breast cancer
2026 · External reference
Cancer survival in England - adults diagnosed
2019 · External reference
Breast Screening Programme, England, 2023-2024. NHS England Digital
2025 · External reference
Population estimates for the UK, England and Wales, Scotland and Northern Ireland - office for national statistics
2019 · External reference
Cancer Survival in England, cancers diagnosed 2016 to 2020, followed up to 2021
2023 · External reference
Breast cancer incidence (invasive) statistics
2025 · External reference
The prognosis of small primary breast cancers
10.1016/s0959-8049(99)00056-8 · 1999 · External reference
The practicability of a novel prognostic index (PI) model and comparison with Nottingham prognostic index (NPI) in stage I–III breast cancer patients undergoing surgical treatment
10.1371/journal.pone.0143537 · 2015 · External reference
Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease
10.1093/jnci/89.18.1356 · 1997 · External reference
Breast density effect on the sensitivity of digital screening mammography in a UK cohort
10.1007/s00330-024-10951-w · 2025 · External reference
Unresolved reference
2022 · External reference
EQ-5D health utility scores: data from a comprehensive Canadian cancer centre
10.1007/s40271-016-0190-z · 2017 · External reference
National cost collection data publication: 2023/24
2024 · External reference
Cost of care for cancer patients in England: evidence from population-based patient-level data
10.1038/bjc.2016.77 · 2016 · External reference
Mortality rates (qx), principal projection, England and Wales - Office For National Statistics
2019 · External reference
A systematic literature review of health utility values
10.1177/0272989x211065471 · 2022 · External reference
Health state utility values by cancer stage: a systematic literature review
10.1007/s10198-021-01335-8 · 2021 · External reference
2018/19 National cost collection data publication
2022 · External reference
Unresolved reference
2022 · External reference
Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420)
10.1038/s41416-023-02250-w · 2023 · External reference
Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial
10.1016/s0140-6736(25)00582-3 · 2025 · External reference
Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial
10.1016/s0140-6736(25)02464-x · 2026 · External reference
Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population
10.1007/s00330-024-11342-x · 2025 · External reference
Radiological audit of interval breast cancers: estimation of tumour growth rates
10.1016/j.breast.2020.03.006 · 2020 · External reference
CanRisk tool-a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants
10.1158/1055-9965.epi-20-1319 · 2021 · External reference
